RIPK3 and Glucose intolerance: Interestingly, WT→RIPK3−/− mice after 16 weeks of CD-HFD presented with a significantly stronger glucose intolerance and higher insulin levels than RIPK3−/−→WT animals (Fig. 6c–e).